Request for Covid-19 Impact Assessment of this Report

Take Action
Medical Devices

Global Overactive Bladder Treatment Drug Market Size, Status and Forecast 2022

  • QYR1412327
  • 105 Pages
  • July 2017
  • Medical Devices
Download Sample    Get Discount   
 
This report studies the global Overactive Bladder Treatment Drug market, analyzes and researches the Overactive Bladder Treatment Drug development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

Astellas Pharma, Inc. (Japan)

Pfizer, Inc. (U.S.)

Teva Pharmaceutical Industries Limited (Israel)

Allergan, Plc (Ireland)

Medtronic plc (Ireland)

Mylan N.V. (U.S.)

Endo International plc (Ireland)

Hisamitsu Pharmaceutical Co., Inc. (Japan)

Sanofi (France)

Apotex, Inc. (Canada)

Cogentix Medical, Inc. (U.S.)

Aurobindo Pharma Limited (India)

Market segment by Regions/Countries, this report covers

United States

EU

Japan

China

India

Southeast Asia

Market segment by Type, Overactive Bladder Treatment Drug can be split into

Anticholinergics

Solifenacin

Oxybutynin

Darifenacin

Fesoterodine

Tolterodine

Trospium

Others

Market segment by Application, Overactive Bladder Treatment Drug can be split into

Idiopathic Bladder Overactivity

Neurogenic Bladder Overactivity

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Overactive Bladder Treatment Drug Market Size, Status and Forecast 2022

1 Industry Overview of Overactive Bladder Treatment Drug

1.1 Overactive Bladder Treatment Drug Market Overview

1.1.1 Overactive Bladder Treatment Drug Product Scope

1.1.2 Market Status and Outlook

1.2 Global Overactive Bladder Treatment Drug Market Size and Analysis by Regions

1.2.1 United States

1.2.2 EU

1.2.3 Japan

1.2.4 China

1.2.5 India

1.2.6 Southeast Asia

1.3 Overactive Bladder Treatment Drug Market by Type

1.3.1 Anticholinergics

1.3.2 Solifenacin

1.3.3 Oxybutynin

1.3.4 Darifenacin

1.3.5 Fesoterodine

1.3.6 Tolterodine

1.3.7 Trospium

1.3.8 Others

1.4 Overactive Bladder Treatment Drug Market by End Users/Application

1.4.1 Idiopathic Bladder Overactivity

1.4.2 Neurogenic Bladder Overactivity

2 Global Overactive Bladder Treatment Drug Competition Analysis by Players

2.1 Overactive Bladder Treatment Drug Market Size (Value) by Players (2016 and 2017)

2.2 Competitive Status and Trend

2.2.1 Market Concentration Rate

2.2.2 Product/Service Differences

2.2.3 New Entrants

2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles

3.1 Astellas Pharma, Inc. (Japan)

3.1.1 Company Profile

3.1.2 Main Business/Business Overview

3.1.3 Products, Services and Solutions

3.1.4 Overactive Bladder Treatment Drug Revenue (Value) (2012-2017)

3.1.5 Recent Developments

3.2 Pfizer, Inc. (U.S.)

3.2.1 Company Profile

3.2.2 Main Business/Business Overview

3.2.3 Products, Services and Solutions

3.2.4 Overactive Bladder Treatment Drug Revenue (Value) (2012-2017)

3.2.5 Recent Developments

3.3 Teva Pharmaceutical Industries Limited (Israel)

3.3.1 Company Profile

3.3.2 Main Business/Business Overview

3.3.3 Products, Services and Solutions

3.3.4 Overactive Bladder Treatment Drug Revenue (Value) (2012-2017)

3.3.5 Recent Developments

3.4 Allergan, Plc (Ireland)

3.4.1 Company Profile

3.4.2 Main Business/Business Overview

3.4.3 Products, Services and Solutions

3.4.4 Overactive Bladder Treatment Drug Revenue (Value) (2012-2017)

3.4.5 Recent Developments

3.5 Medtronic plc (Ireland)

3.5.1 Company Profile

3.5.2 Main Business/Business Overview

3.5.3 Products, Services and Solutions

3.5.4 Overactive Bladder Treatment Drug Revenue (Value) (2012-2017)

3.5.5 Recent Developments

3.6 Mylan N.V. (U.S.)

3.6.1 Company Profile

3.6.2 Main Business/Business Overview

3.6.3 Products, Services and Solutions

3.6.4 Overactive Bladder Treatment Drug Revenue (Value) (2012-2017)

3.6.5 Recent Developments

3.7 Endo International plc (Ireland)

3.7.1 Company Profile

3.7.2 Main Business/Business Overview

3.7.3 Products, Services and Solutions

3.7.4 Overactive Bladder Treatment Drug Revenue (Value) (2012-2017)

3.7.5 Recent Developments

3.8 Hisamitsu Pharmaceutical Co., Inc. (Japan)

3.8.1 Company Profile

3.8.2 Main Business/Business Overview

3.8.3 Products, Services and Solutions

3.8.4 Overactive Bladder Treatment Drug Revenue (Value) (2012-2017)

3.8.5 Recent Developments

3.9 Sanofi (France)

3.9.1 Company Profile

3.9.2 Main Business/Business Overview

3.9.3 Products, Services and Solutions

3.9.4 Overactive Bladder Treatment Drug Revenue (Value) (2012-2017)

3.9.5 Recent Developments

3.10 Apotex, Inc. (Canada)

3.10.1 Company Profile

3.10.2 Main Business/Business Overview

3.10.3 Products, Services and Solutions

3.10.4 Overactive Bladder Treatment Drug Revenue (Value) (2012-2017)

3.10.5 Recent Developments

3.11 Cogentix Medical, Inc. (U.S.)

3.12 Aurobindo Pharma Limited (India)

4 Global Overactive Bladder Treatment Drug Market Size by Type and Application (2012-2017)

4.1 Global Overactive Bladder Treatment Drug Market Size by Type (2012-2017)

4.2 Global Overactive Bladder Treatment Drug Market Size by Application (2012-2017)

4.3 Potential Application of Overactive Bladder Treatment Drug in Future

4.4 Top Consumer/End Users of Overactive Bladder Treatment Drug

5 United States Overactive Bladder Treatment Drug Development Status and Outlook

5.1 United States Overactive Bladder Treatment Drug Market Size (2012-2017)

5.2 United States Overactive Bladder Treatment Drug Market Size and Market Share by Players (2016 and 2017)

6 EU Overactive Bladder Treatment Drug Development Status and Outlook

6.1 EU Overactive Bladder Treatment Drug Market Size (2012-2017)

6.2 EU Overactive Bladder Treatment Drug Market Size and Market Share by Players (2016 and 2017)

7 Japan Overactive Bladder Treatment Drug Development Status and Outlook

7.1 Japan Overactive Bladder Treatment Drug Market Size (2012-2017)

7.2 Japan Overactive Bladder Treatment Drug Market Size and Market Share by Players (2016 and 2017)

8 China Overactive Bladder Treatment Drug Development Status and Outlook

8.1 China Overactive Bladder Treatment Drug Market Size (2012-2017)

8.2 China Overactive Bladder Treatment Drug Market Size and Market Share by Players (2016 and 2017)

9 India Overactive Bladder Treatment Drug Development Status and Outlook

9.1 India Overactive Bladder Treatment Drug Market Size (2012-2017)

9.2 India Overactive Bladder Treatment Drug Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Overactive Bladder Treatment Drug Development Status and Outlook

10.1 Southeast Asia Overactive Bladder Treatment Drug Market Size (2012-2017)

10.2 Southeast Asia Overactive Bladder Treatment Drug Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)

11.1 Global Overactive Bladder Treatment Drug Market Size (Value) by Regions (2017-2022)

11.1.1 United States Overactive Bladder Treatment Drug Revenue and Growth Rate (2017-2022)

11.1.2 EU Overactive Bladder Treatment Drug Revenue and Growth Rate (2017-2022)

11.1.3 Japan Overactive Bladder Treatment Drug Revenue and Growth Rate (2017-2022)

11.1.4 China Overactive Bladder Treatment Drug Revenue and Growth Rate (2017-2022)

11.1.5 India Overactive Bladder Treatment Drug Revenue and Growth Rate (2017-2022)

11.1.6 Southeast Asia Overactive Bladder Treatment Drug Revenue and Growth Rate (2017-2022)

11.2 Global Overactive Bladder Treatment Drug Market Size (Value) by Type (2017-2022)

11.3 Global Overactive Bladder Treatment Drug Market Size by Application (2017-2022)

12 Overactive Bladder Treatment Drug Market Dynamics

12.1 Overactive Bladder Treatment Drug Market Opportunities

12.2 Overactive Bladder Treatment Drug Challenge and Risk

12.2.1 Competition from Opponents

12.2.2 Downside Risks of Economy

12.3 Overactive Bladder Treatment Drug Market Constraints and Threat

12.3.1 Threat from Substitute

12.3.2 Government Policy

12.3.3 Technology Risks

12.4 Overactive Bladder Treatment Drug Market Driving Force

12.4.1 Growing Demand from Emerging Markets

12.4.2 Potential Application

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs Trend/Customer Preference

13.3 External Environmental Change

13.3.1 Economic Fluctuations

13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Overactive Bladder Treatment Drug Product Scope

Figure Global Overactive Bladder Treatment Drug Market Size (Million USD) (2012-2017)

Table Global Overactive Bladder Treatment Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Global Overactive Bladder Treatment Drug Market Share by Regions in 2016

Figure United States Overactive Bladder Treatment Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure EU Overactive Bladder Treatment Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Japan Overactive Bladder Treatment Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure China Overactive Bladder Treatment Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure India Overactive Bladder Treatment Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Southeast Asia Overactive Bladder Treatment Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Global Overactive Bladder Treatment Drug Market Share by Type in 2016

Figure Anticholinergics Market Size (Million USD) and Growth Rate (2012-2017)

Figure Solifenacin Market Size (Million USD) and Growth Rate (2012-2017)

Figure Oxybutynin Market Size (Million USD) and Growth Rate (2012-2017)

Figure Darifenacin Market Size (Million USD) and Growth Rate (2012-2017)

Figure Fesoterodine Market Size (Million USD) and Growth Rate (2012-2017)

Figure Tolterodine Market Size (Million USD) and Growth Rate (2012-2017)

Figure Trospium Market Size (Million USD) and Growth Rate (2012-2017)

Figure Others Market Size (Million USD) and Growth Rate (2012-2017)

Figure Global Overactive Bladder Treatment Drug Market Share by Application in 2016

Table Key Downstream Customer in Idiopathic Bladder Overactivity

Figure Overactive Bladder Treatment Drug Market Size (Million USD) and Growth Rate in Idiopathic Bladder Overactivity (2012-2017)

Table Key Downstream Customer in Neurogenic Bladder Overactivity

Figure Overactive Bladder Treatment Drug Market Size (Million USD) and Growth Rate in Neurogenic Bladder Overactivity (2012-2017)

Figure Overactive Bladder Treatment Drug Market Size (Million USD) and Growth Rate in Applications 3 (2012-2017)

Table Overactive Bladder Treatment Drug Market Size (Million USD) by Players (2016 and 2017)

Figure Overactive Bladder Treatment Drug Market Size Share by Players in 2016

Figure Overactive Bladder Treatment Drug Market Size Share by Players in 2017

Table Astellas Pharma, Inc. (Japan) Basic Information List

Table Overactive Bladder Treatment Drug Business Revenue (Million USD) of Astellas Pharma, Inc. (Japan) (2012-2017)

Figure Astellas Pharma, Inc. (Japan) Overactive Bladder Treatment Drug Business Revenue Market Share in 2016

Table Pfizer, Inc. (U.S.) Basic Information List

Table Overactive Bladder Treatment Drug Business Revenue (Million USD) of Pfizer, Inc. (U.S.) (2012-2017)

Figure Pfizer, Inc. (U.S.) Overactive Bladder Treatment Drug Business Revenue Market Share in 2016

Table Teva Pharmaceutical Industries Limited (Israel) Basic Information List

Table Overactive Bladder Treatment Drug Business Revenue (Million USD) of Teva Pharmaceutical Industries Limited (Israel) (2012-2017)

Figure Teva Pharmaceutical Industries Limited (Israel) Overactive Bladder Treatment Drug Business Revenue Market Share in 2016

Table Allergan, Plc (Ireland) Basic Information List

Table Overactive Bladder Treatment Drug Business Revenue (Million USD) of Allergan, Plc (Ireland) (2012-2017)

Figure Allergan, Plc (Ireland) Overactive Bladder Treatment Drug Business Revenue Market Share in 2016

Table Medtronic plc (Ireland) Basic Information List

Table Overactive Bladder Treatment Drug Business Revenue (Million USD) of Medtronic plc (Ireland) (2012-2017)

Figure Medtronic plc (Ireland) Overactive Bladder Treatment Drug Business Revenue Market Share in 2016

Table Mylan N.V. (U.S.) Basic Information List

Table Overactive Bladder Treatment Drug Business Revenue (Million USD) of Mylan N.V. (U.S.) (2012-2017)

Figure Mylan N.V. (U.S.) Overactive Bladder Treatment Drug Business Revenue Market Share in 2016

Table Endo International plc (Ireland) Basic Information List

Table Overactive Bladder Treatment Drug Business Revenue (Million USD) of Endo International plc (Ireland) (2012-2017)

Figure Endo International plc (Ireland) Overactive Bladder Treatment Drug Business Revenue Market Share in 2016

Table Hisamitsu Pharmaceutical Co., Inc. (Japan) Basic Information List

Table Overactive Bladder Treatment Drug Business Revenue (Million USD) of Hisamitsu Pharmaceutical Co., Inc. (Japan) (2012-2017)

Figure Hisamitsu Pharmaceutical Co., Inc. (Japan) Overactive Bladder Treatment Drug Business Revenue Market Share in 2016

Table Sanofi (France) Basic Information List

Table Overactive Bladder Treatment Drug Business Revenue (Million USD) of Sanofi (France) (2012-2017)

Figure Sanofi (France) Overactive Bladder Treatment Drug Business Revenue Market Share in 2016

Table Apotex, Inc. (Canada) Basic Information List

Table Overactive Bladder Treatment Drug Business Revenue (Million USD) of Apotex, Inc. (Canada) (2012-2017)

Figure Apotex, Inc. (Canada) Overactive Bladder Treatment Drug Business Revenue Market Share in 2016

Table Cogentix Medical, Inc. (U.S.) Basic Information List

Table Overactive Bladder Treatment Drug Business Revenue (Million USD) of Cogentix Medical, Inc. (U.S.) (2012-2017)

Figure Cogentix Medical, Inc. (U.S.) Overactive Bladder Treatment Drug Business Revenue Market Share in 2016

Table Aurobindo Pharma Limited (India) Basic Information List

Table Overactive Bladder Treatment Drug Business Revenue (Million USD) of Aurobindo Pharma Limited (India) (2012-2017)

Figure Aurobindo Pharma Limited (India) Overactive Bladder Treatment Drug Business Revenue Market Share in 2016

Table Global Overactive Bladder Treatment Drug Market Size (Million USD) by Type (2012-2017)

Figure Global Overactive Bladder Treatment Drug Market Size Share by Type in 2012

Figure Global Overactive Bladder Treatment Drug Market Size Share by Type in 2013

Figure Global Overactive Bladder Treatment Drug Market Size Share by Type in 2014

Figure Global Overactive Bladder Treatment Drug Market Size Share by Type in 2015

Figure Global Overactive Bladder Treatment Drug Market Size Share by Type in 2016

Figure Global Overactive Bladder Treatment Drug Market Size Share by Type in 2017

Table Global Overactive Bladder Treatment Drug Market Size (Million USD) by Application (2012-2017)

Figure Global Overactive Bladder Treatment Drug Market Size (Million USD) by Application in 2012

Figure Global Overactive Bladder Treatment Drug Market Size (Million USD) by Application in 2013

Figure Global Overactive Bladder Treatment Drug Market Size (Million USD) by Application in 2014

Figure Global Overactive Bladder Treatment Drug Market Size (Million USD) by Application in 2015

Figure Global Overactive Bladder Treatment Drug Market Size (Million USD) by Application in 2016

Figure Global Overactive Bladder Treatment Drug Market Size (Million USD) by Application in 2017

Table Top Consumer/End Users of Overactive Bladder Treatment Drug

Figure United States Overactive Bladder Treatment Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table United States Overactive Bladder Treatment Drug Market Size (Million USD) by Players (2012-2017)

Figure United States Overactive Bladder Treatment Drug Market Size Share by Players in 2016

Figure United States Overactive Bladder Treatment Drug Market Size Share by Players in 2017

Figure EU Overactive Bladder Treatment Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table EU Overactive Bladder Treatment Drug Market Size (Million USD) by Players (2012-2017)

Figure EU Overactive Bladder Treatment Drug Market Size Share by Players in 2016

Figure EU Overactive Bladder Treatment Drug Market Size Share by Players in 2017

Figure Japan Overactive Bladder Treatment Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table Japan Overactive Bladder Treatment Drug Market Size (Million USD) by Players (2012-2017)

Figure Japan Overactive Bladder Treatment Drug Market Size Share by Players in 2016

Figure Japan Overactive Bladder Treatment Drug Market Size Share by Players in 2017

Figure China Overactive Bladder Treatment Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table China Overactive Bladder Treatment Drug Market Size (Million USD) by Players (2012-2017)

Figure China Overactive Bladder Treatment Drug Market Size Share by Players in 2016

Figure China Overactive Bladder Treatment Drug Market Size Share by Players in 2017

Figure India Overactive Bladder Treatment Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table India Overactive Bladder Treatment Drug Market Size (Million USD) by Players (2012-2017)

Figure India Overactive Bladder Treatment Drug Market Size Share by Players in 2016

Figure India Overactive Bladder Treatment Drug Market Size Share by Players in 2017

Figure Southeast Asia Overactive Bladder Treatment Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table Southeast Asia Overactive Bladder Treatment Drug Market Size (Million USD) by Players (2012-2017)

Figure Southeast Asia Overactive Bladder Treatment Drug Market Size Share by Players in 2016

Figure Southeast Asia Overactive Bladder Treatment Drug Market Size Share by Players in 2017

Figure Global Overactive Bladder Treatment Drug Market Size (Million USD) by Regions (2017-2022)

Table Global Overactive Bladder Treatment Drug Market Size (Million USD) by Regions (2017-2022)

Figure Global Overactive Bladder Treatment Drug Market Size Share by Regions in 2017

Figure Global Overactive Bladder Treatment Drug Market Size Share by Regions in 2022

Figure United States Overactive Bladder Treatment Drug Revenue (Million USD) and Growth Rate (2017-2022)

Figure EU Overactive Bladder Treatment Drug Revenue (Million USD) and Growth Rate (2017-2022)

Figure Japan Overactive Bladder Treatment Drug Revenue (Million USD) and Growth Rate (2017-2022)

Figure China Overactive Bladder Treatment Drug Revenue (Million USD) and Growth Rate (2017-2022)

Figure India Overactive Bladder Treatment Drug Revenue (Million USD) and Growth Rate (2017-2022)

Figure Southeast Asia Overactive Bladder Treatment Drug Revenue (Million USD) and Growth Rate (2017-2022)

Table Global Overactive Bladder Treatment Drug Market Size (Million USD) by Type (2017-2022)

Figure Global Overactive Bladder Treatment Drug Market Size Share by Type in 2017

Figure Global Overactive Bladder Treatment Drug Market Size Share by Type in 2022

Table Global Overactive Bladder Treatment Drug Market Size (Million USD) by Application (2017-2022)

Figure Global Overactive Bladder Treatment Drug Market Size (Million USD) by Application in 2017

Figure Global Overactive Bladder Treatment Drug Market Size (Million USD) by Application in 2022

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
View Details
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370
View Details
Laparoscopy Devices Market by Product (Laparoscopes, Energy Devices, Insufflators, Robot-Assisted Surgery Systems, Suction or Irrigation Systems, Closure Devices, Hand Instruments, Access Devices, Accessories, and Other Laparoscopy Devices), Application {General Surgery (Cholecystectomies, Hernia Repairs, Appendectomies, Anti-reflux Surgeries, and Others), Bariatric Surgery (Gastric Bypass, Sleeve gastrectomy, Gastric Banding, and Others), Gynecological Surgery, Urological Surgery, Colorectal Surgery, and Others}, and End User (Hospitals, Clinics, and Other End Users) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...

  • Publish Date: April 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research